February 06, 2017
Altimmune to Present at the BIO CEO & Investor Conference
Media
February 06, 2017
Targovax ASA: Invitation to fourth quarter and full year 2016 results presentation Thursday 16 February
February 06, 2017
Q4 2016 General Market Overview
February 02, 2017
Targovax announces encouraging top line two-year survival data from TG01 clinical trial in resected pancreatic cancer patients
February 02, 2017
Strongbridge Biopharma plc to Participate in the Canaccord Genuity Rare Disease and BioPharma One-on-One Day
January 31, 2017
Neurosurgeons from Germany and U.S.A. report on their clinical experience of using Nexstim NBS system
January 31, 2017
Radiotherapy, immunotherapy and DNA repair inhibitors: a winning combination towards the oncology of the future
January 31, 2017
GenSight Biologics receives FDA Orphan Drug Designation for GS030 in Retinitis Pigmentosa
January 27, 2017
GenSight Biologics reports its cash position as of December 31, 2016
January 24, 2017
Onxeo Completes Enrollment in Phase III Study of Livatag® for the Treatment of Hepatocellular Carcinoma